Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (230)

2023

  1. Best practices during COVID-19 pandemic in solid organ transplant programs in Spain

    Transplantation Reviews, Vol. 37, Núm. 1

2022

  1. Anti-myeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in anti-neutrophil cytoplasmic antibody-associated vasculitis

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 4, pp. 697-704

  2. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study

    Clinical transplantation, Vol. 36, Núm. 3, pp. e14550

  3. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients

    Transplantation, Vol. 106, Núm. 7, pp. 1430-1439

2021

  1. Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a spanish multicenter cohort

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 5

  2. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19

    Kidney International Reports, Vol. 6, Núm. 9, pp. 2305-2315

2020

  1. Risk factors for non-diabetic renal disease in diabetic patients

    Clinical Kidney Journal, Vol. 13, Núm. 3, pp. 380-388

2018

  1. Chagas disease recommendations for solid-organ transplant recipients and donors

    Transplantation, Vol. 102, Núm. 2S, pp. S1-S7

  2. Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation

    Clinical Microbiology and Infection, Vol. 24, Núm. 2, pp. 192-198

2016

  1. Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 11, pp. 3220-3234

  2. Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case–Control Study

    American Journal of Transplantation, Vol. 16, Núm. 7, pp. 2148-2157

  3. Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients

    Transplant Infectious Disease, Vol. 18, Núm. 6, pp. 819-831

  4. Steroid avoidance or withdrawal for kidney transplant recipients

    Cochrane Database of Systematic Reviews, Vol. 2016, Núm. 8

2015

  1. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185

2014

  1. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients

    Cochrane Database of Systematic Reviews, Vol. 2014, Núm. 9

2013

  1. The impact of darbepoietin alfa in early post-transplant anaemia management: Retrospective exploratory study

    Nefrologia, Vol. 33, Núm. 1, pp. 107-115

2012

  1. Very early steroid withdrawal or complete avoidance for kidney transplant recipients: A systematic review

    Nephrology Dialysis Transplantation, Vol. 27, Núm. 2, pp. 825-832

2011

  1. Author's reply: Cyclosporine a versus tacrolimus in steroid withdrawal strategies

    Transplantation

2010

  1. A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation

    Transplantation, Vol. 90, Núm. 4, pp. 343-349

  2. Immunosuppressive therapy and infection after kidney transplantation

    Transplant Infectious Disease, Vol. 12, Núm. 5, pp. 397-405